Survival in Patients With Hematologic Cancers and COVID-19
This cohort study evaluated the association of convalescent plasma treatment with 30-day mortality in hospitalized adults with hematologic cancers and COVID-19.
Related Articles
What Bladder Cancer Treatments are Available?
Jung Gong, MD, talks about bladder cancer. Which groups are the most affected? What types of treatments are available?
‘Godfather of AI’ raises odds of the technology wiping out humanity over next 30 years
Geoffrey Hinton says there is 10-20% chance AI will lead to human extinction in next three decades amid fast pace of change
When to Stay or Leave Your Physician Job – FREE Webinar
At the free, LIVE class, you’ll get everything you need to make your decision & upgrade your job in 2025, regardless if you stay or…
Weather Impact Alert issued for Saturday due to threat of severe storms
The Houston area is under a Level 2 out of 5, meaning a slight risk for severe weather.
Longtime CBS Sports anchor Greg Gumbel dies at 78
He was a studio host of CBS Sports’ NCAA Division I Men’s Basketball coverage who had been covering sports for over 50 years.
Tell your Senators: Oppose Kennedy for Health and Human Services Secretary
Please contact Congress now!
Myeloma Paper of the Day, December 27th, suggested by Robert Orlowski – OncoDaily
Myeloma Paper of the Day, December 27th, suggested by Robert Orlowski / Ahmad Basharat, Ahmed Hebishy, cancer, hematopoietic stem cell transplant, Iqra Anwar,
Characterization of bleeding in thrombotic thrombocytopenic purpura in the precaplacizumab era: a retrospective nationwide analysis
The addition of caplacizumab to immune thrombotic thrombocytopenia (iTTP) treatment options has led to a renewed interest in characterizing the epidemiology and risk factors for…
Paper: Phase 3 Study of Teclistamab (Tec) in Combination with Lenalidomide (Len) and Tec Alone Versus Len Alone in Newly Diagnosed Multiple Myeloma (NDMM) As Maintenance Therapy Following Autologous Stem Cell Transplantation (ASCT): Safety Run-in (SRI) Results from the Majestec-4/EMN30 Trial
Program: Oral and Poster Abstracts Type: Oral Session: 654. Multiple Myeloma: Pharmacologic Therapies: Targeting BCMA Hematology Disease Topics & Pathways: Research, Clinical trials, Bispecific Antibody…
Hippopotomonstrosesquippedaliophobia: a made-up word for a made-up condition but I’m OK with that
Thagomizer, “the distinctive arrangement of four spikes on the tails of stegosaurian dinosaurs”, is a word that made the most unusual jump from a cartoon…
